G42 Healthcare Launches Health AI Services to Accelerate COVID-19 Diagnosis and Drug Discovery | Invent a Better Everyday | Abu Dhabi, UAE | G42

G42 Healthcare launched its G42 Health AI Platform on May 19, 2020, to enhance COVID-19 diagnosis and drug discovery. This cloud-based solution provides advanced tools for researchers and medical organizations globally, aiming to speed up the detection of the virus and facilitate drug development. The platform includes services like Virus Genome Analysis, AI-Assisted CT Scan Evaluation, and In Silico Drug Discovery. These tools enable rapid identification of the virus's genome and improve diagnostic accuracy, crucial for effective pandemic response.